Clinical Trial Update: Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the feasibility and safety of nintedanib in combination with nivolumab in pretreated advanced or metastatic adenocarcinoma of the lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung

Drugs mentioned

• Nintedanib (nintedanib)
• nivolumab (nivolumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Adenocarcinoma of the Lung | Phase 1, Phase 2 | Status: COMPLETED